The treatment landscape of hormone receptor–positive, HER2-negative metastatic breast cancer has become increasingly crowded, ...
Decoding T Cell Exhaustion in the Tumour Microenvironment / cancer, cancer immunotherapy, Experimental and Molecular Medicine ...
Delighted to Start New Role as Director of National Oncology Centre in Oman / Abdallah Al Alawi, cancer, Muscat, Oman, ...
Bringing New Perspectives in Lung Cancer Care to Georgia - European School of Oncology / cancer, cancer care, clinical ...
What Does It Take to Turn a Research Idea Into a Clinical Trial? - European Hematology Association / cancer, clinical ...
A Great Lung Cancer Congress for Latin America / cancer, Edgardo Santos, Lung cancer, Lung Cancer Congress, OncoDaily, ...
Fabio Ynoe de Moraes, Associate Professor at Queen’s University, Visiting Adjunct Professor at University of São Paulo, ...
What’s New in the Classification of Bladder Neuroendocrine Tumors? / Anandi Lobo, APOBEC-related changes, ASCL1, bladder ...
What If We Could Reprogram the Signaling That Drives T-Cell Lymphoma? / cancer, lymphoma, OncoDaily, Oncology, T-cell ...
CAR T-cell therapy has transformed the treatment of several relapsed or refractory hematologic malignancies, producing deep ...
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: “From Guidelines to Real-World Clinical Practice. I’m proud to be invited to ta ...
IHCRI Rwanda to Host at London Global Cancer Week 2026 / cancer, IHCRI-Rwanda, LGCW, London Global Cancer Week 2026, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results